Výsledky vyhledávání - "V I Ignatieva"

Akademický článek

Pharmacoeconomic analysis of epidermal growth factor (HeberprotP ®) for the treatment of diabetic foot ulcers

Autor: G R Galstyan, V I Ignatieva, M V Avksentieva, I I Dedov

Publikováno v: Эндокринная хирургия, Vol 7, Iss 1, Pp 4-15 (2013)

Introduction. The epidermal growth factor (EGF; HeberprotP ®) is the new treatment for deep persistent diabetic foot ulcers (Wagner grade 3–4). The effectiveness of EGF measured as the reduction of the time to complete granulation of tissue lesion

Externí odkaz: https://doaj.org/article/3f451afd8d5f487084790c44f44273b1

Zobrazit plný text záznamu

Akademický článek

Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure

Autor: V. I. Ignatieva, A. V. Kontsevaya, M. M. Lukyanov, V. G. Klyashtorny, O. M. Drapkina

Publikováno v: Кардиоваскулярная терапия и профилактика, Vol 23, Iss 4 (2024)

Aim. To make a cost-effectiveness analysis of increasing the prescription rate of combination therapy with beta-blockers (BBs), angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), statins and oral anticoagulants (O

Externí odkaz: https://doaj.org/article/7bc152c45d56481bb0e3169f3a5c345a

Zobrazit plný text záznamu

Akademický článek

Economics of cardiovascular prevention in the Russian Federation

Autor: A. V. Kontsevaya, D. K. Mukaneeva, V. I. Ignatieva, A. A. Antsiferova, O. M. Drapkina

Publikováno v: Российский кардиологический журнал, Vol 28, Iss 9 (2023)

Cardiovascular diseases (CVDs) are the leading threat to the population health in the Russian Federation (RF), ranking first in the mortality structure. Demonstration of the economic impact of CVD is a rationale for investing in prevention and treatm

Externí odkaz: https://doaj.org/article/6de167196e46401289665f8b2750353b

Zobrazit plný text záznamu

Akademický článek

Socio-economic impact of heart failure in Russia

Autor: O. M. Drapkina, S. A. Boytsov, V. V. Omelyanovskiy, A. V. Kontsevaya, M. M. Loukianov, V. I. Ignatieva, E. V. Derkach

Publikováno v: Российский кардиологический журнал, Vol 26, Iss 6 (2021)

Heart failure (HF) significantly worsens the patient quality of life and leads to the disability of their significant part, as well as increases the risk of death, which in turn causes economic damage.Aim. To assess the annual socio-economic impact o

Externí odkaz: https://doaj.org/article/4d4a5884e8294c468ee1d19085463c51

Zobrazit plný text záznamu

LONG-TERM TREATMENT OUTCOMES IN COMMUNITY-ACQUIRED COVID-19 VIRAL PNEUMONIA ASSESSED BY COMPUTED TOMOGRAPHY DATA

Autor: O. K. Yakovenk, V. I. Ignatieva, G. L. Gumeniuk, O. R. Tarasenko, V. A. Svyatnenko, M. I. Lynnyk

Publikováno v: Ukrainian Pulmonology Journal. 30:37-41

The aim was to study the evolution of changes in the structure of the lungs in patients with a complicated course of community-acquired COVID-19 viral pneumonia by software processing of CT scan data and to determine the features of changes to predic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::03b3e03b204d80e0d9c76bf46234919f
https://doi.org/10.31215/2306-4927-2022-30-2-37-41

Zobrazit plný text záznamu

Akademický článek

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation

Autor: V. I. Ignatieva, M. V. Avksentieva

Publikováno v: Онкогематология, Vol 10, Iss 2, Pp 14-25 (2015)

Introduction. Based on clinical studies data voriconazole is recommended as the drug of choice for treatment of invasive aspergillosis (IA) – a widespread infectious complications occurring in immunocompromised patients and is characterized by seve

Externí odkaz: https://doaj.org/article/f56907652c814e23a05db8f627a5feaa

Zobrazit plný text záznamu

CURRENT ISSUES OF BRONCHIAL ASTHMA 2021: WORLD ASTHMA DAY AND THE IMPACT OF THE COVID-19 PANDEMIC

Autor: S. G. Opimakh, V. I. Ignatieva, G. L. Gumeniuk

Publikováno v: Asthma and allergy. 2021:21-26

This year’s World Asthma Day has the theme “Uncovering Asthma Misconceptions”. This position calls for action and action to clarify common myths and misconceptions about asthma that prevent asthma sufferers from receiving optimal benefits from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9501194bf9329a42e1052504b04fa4aa
https://doi.org/10.31655/2307-3373-2021-2-21-26

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání